Precision diagnostic service utilizing liquid biopsy technology for early detection and monitoring of malignant tumors. Analyzes circulating biomarkers from patient blood samples. Enables non-invasive assessment of tumor characteristics and treatment response.
Manufactured by
China
NOROVA specializes in personalized precision medicine for malignant tumors, serving as a biomedical innovation and life sciences R&D center in the Beijing-Tianjin region. The company operates a proprietary tumor organoid precision diagnosis platform integrating drug sensitivity testing, high-throughput drug screening, and genetic testing. NOROVA also develops tumor microenvironment organ-on-chip and multi-organ chip technologies for drug development applications.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
GENETRON HEALTH (BEIJING) CO., LTD
China · 2 relevant products
Eone-Diagnomics Genome Center
South Korea · 2 relevant products
guangzhou biotron technolongy co.,ltd
China · 5 relevant products
Biopsense Oy
Finland · 4 relevant products
Bio-Techne Diagnostics
United States · 2 relevant products
GeneCker Co., Ltd.
South Korea · 2 relevant products
Glycanostics, s.r.o.
Slovakia · 2 relevant products
Labcorp
United States · 3 relevant products
Qiagen
United States · 1 relevant product
Dxome Co., Ltd.
South Korea · 1 relevant product
41 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →6 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 84 closest product alternatives
GENETRON HEALTH (BEIJING) CO., LTD · China
Molecular diagnostic test utilizing circulating tumor DNA and biomarkers from blood samples. Enables non-invasive cancer screening and early detection. Supports monitoring of treatment response and recurrence in cancer patients.
Eone-Diagnomics Genome Center · South Korea
Blood-based diagnostic testing methodology for non-invasive detection of genetic abnormalities and disease markers. Uses advanced sequencing techniques to analyze circulating DNA and genetic material.
guangzhou biotron technolongy co.,ltd · China
Advanced liquid biopsy system for non-invasive detection and analysis of circulating tumor markers, circulating tumor cells, and cell-free DNA from blood samples.
Biopsense Oy · Finland
Liquid biopsy diagnostic solution for non-invasive cancer monitoring and treatment personalization through cell-free DNA analysis. Automates plasma separation, DNA extraction, and quantitation to reduce pre-analytical variability and enable frequent patient monitoring for improved treatment response assessment.
Bio-Techne Diagnostics · United States
Advanced molecular assays for liquid biopsy applications enabling non-invasive detection of circulating biomarkers. Integrated with automated analysis for scalable clinical implementation.
GeneCker Co., Ltd. · South Korea
Integrated platform for cancer diagnosis utilizing liquid biopsy techniques with CRISPR/Cas9 technology. Includes complete workflow from sample collection through DNA sequencing to result analysis.
Glycanostics, s.r.o. · Slovakia
Non-invasive liquid biopsy test for early-stage prostate cancer detection using glycan analysis in blood serum. Achieves up to 90% accuracy using magnetic particle-based technology with minimal blood sample requirement of 10 microliters.
Labcorp · United States
Advanced blood-based testing for detection of circulating tumor DNA and other biomarkers. Provides non-invasive alternatives to tissue biopsy for cancer diagnosis and monitoring.
Qiagen · United States
A diagnostic test for oncology applications designed to detect genetic variations in solid tumors. It supports cancer research and precision oncology workflows.
Dxome Co., Ltd. · South Korea
A cutting-edge liquid biopsy product that analyzes circulating tumor DNA (ctDNA) to identify somatic mutations. It aids in treatment selection, response monitoring, and recurrence detection for optimal cancer care.
guangzhou biotron technolongy co.,ltd · China
Liquid biopsy assay for real-time monitoring of circulating tumor markers and cells during perioperative periods to assess surgical outcomes and recurrence risk.
Singlera GENOMICS (SHANGHAI) Ltd. · China
A liquid biopsy-based test utilizing DNA methylation markers for post-treatment cancer recurrence monitoring and surveillance. Enables early detection of disease relapse and progression.
72 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products